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Abstracts 481
not readmitted during the same period served as a con-
trol. Demographic, social and medical details were com-
pared between both groups.
RESULTS: No significant difference regarding age, gender,
sight, hearing, continence or mobility between both
groups. Living alone, with family, or residential care was
not significant. In the study group, 25 (50%) had five or
more weekly contacts with social services compared to 10
(20%) in the control (p  .001). Fourty (80%) of patients
who were readmitted had more than two co-morbidities
compared to 10 (20%) in the control group (p  .0001).
Heart failure was the most common readmission diagnosis
involving 18 (36%) of the study group and 6 (12%) of the
control (p  .001). Mean length of hospital stay was sig-
nificantly higher in the readmission group—21.06 days
compared to 13.44 days in control (p  .001). Most pa-
tients were readmitted within the first two weeks of dis-
charge (34 vs. 16) and the majority was for a relapse or
complication of the original condition (29 vs. 5).
CONCLUSIONS: Most readmissions are due to medical
factors. Risk groups are those with multiple co-morbidity
and/or who are dependent on social services. The major-
ity was due to relapse of the original condition, which
tends to present early. Patients with heart failure had
more readmissions than other patients with other comor-
bid diagnoses. Early review of high-risk patients may pre-
vent readmission.
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OBJECTIVE: To examine physician variation in admit-
ting patients to Intensive Care Units, using criteria re-
ported in the literature. Study Design: Prospective Survey.
Setting: randomly selected hospitals across Ontario, with
four or more ICU beds. Study Subjects: Physicians who
admit patients to the ICU from hospital emergency de-
partments. Interventions: None.
METHODS: We developed a survey based on 13 unique
scenarios in which were embedded varying risks includ-
ing: the complexity of the condition, acuteness of care re-
quired, and potential of survival. Variables that might in-
fluence physician’s decision to admit the patient to the
ICU were part of each response criteria. These included
age, the presence of advanced directives, patient and fam-
ily preferences, and availability of beds.
RESULTS: Out of 632 questionnaires sent out, 148 were
returned (23.4%). We found that patient age (33 yrs vs
73 yrs), presence of advanced directives and bed avail-
ability had a significant impact on admission decisions
(p  .001). Scenarios that implied an immediate need for
ICU intervention, higher probability of survival and ICU
staffing also had a significant impact on the decision (p 
.001). Irrespective of age, patients with no advanced di-
rectives were admitted to the ICU at the same rate as pa-
tients whose families asked that all measures be taken to
save the patient (p  .001).
CONCLUSIONS: Physician preferences, patient acute-
ness and ICU resource availability influence admission
decisions to the ICU. This finding is interesting consider-
ing that most physicians do not elicit advanced directives
from patients or their caregivers prior to an ICU admis-
sion. However, physicians’ responses indicate that ad-
vanced directives is the most important factor influencing
admission. The opportunity to utilize these findings in
the development of guidelines for ICU admissions will
form part of our ongoing research.
PHP25
THE USE OF ATC/DDD METHODOLOGY FOR 
REVIEWING COST OF DRUG EXPOSURE AT THE 
NATIONAL LEVEL
Borissov BN, Popova MJ, Koulaksazova RA
Bulgarian Drug Agency, Sofia, Bulgaria
OBJECTIVES: To compare the cost per day of one pa-
tient (from 1000 inhabitants) exposure to 5 drug groups.
METHODS: Data have been collected from: a) the im-
port of wholesalers, b) the local industry sale reports for
the domestic market. Drug consumption has been ex-
pressed by means of ATC/DDD methodology for the
groups A (Alimentary), C (Cardiovascular), J (General
antiinfectives), N (Nervous), R (Respiratory). Drug con-
sumption for the same groups has been expressed in
terms of cost in BGN. The cost of one patient (from 1000
inhabitants) exposure per day to a certain drug group has
been calculated for each one of the selected groups.
RESULTS: Drug consumption in DDD/1000/day: A—
91.5, C—127.2, J—17.1, N—55.0 and R—30.8 in 1999,
and 104.4, 114.0, 21.7, 70.9, and 19.7 in 2000, respec-
tively. The cost in pecuniary units /mil. BGN correspond-
ing to the above mentioned values: 40.43; 50.13; 38.81;
42.05, and 22.64 in 1999, and 42.40, 37.67, 55.88,
51.36, and 21.14 in 2000, respectively. Cost of drug ex-
posure of one patient from 1000 (in mil. BGN): A—0.44;
C—0.39; J—2.27; N—0.76, and R—0.74 in 1999, and
0.41, 0.33, 2.58, 0.72, and 1.07 in 2000, respectively. Al-
though group C has shown highest consumption in terms
of cost and DDD/1000/day it has shown the lowest value
in terms of cost of drug exposure for one patient. Group J
shows the highest value in terms of cost of drug exposure
for one patient, although its consumption measured by
cost in BGN and in DDD/1000/day is in fourth and fifth
place, respectively.
CONCLUSIONS: Cost of drug exposure for one patient
analysis is a more reliable indicator than the cost analysis
of sales. It may be used by drug policy makers as it mea-
sures drug expenditures under standardized conditions.
